Literature DB >> 6893122

Electron microscopy in the diagnosis of neuroblastoma.

J B Taxy.   

Abstract

I review the accumulated knowledge regarding the electron microscopy of neuroblastic tumors using a retrospective study of 13 primarily small cell neoplasms for which the diagnosis of a neuroblastic tumor (neuroblastoma, ganglioneuroblastoma, ganglioneuroma) was either considered or eventually established. A fine fibrillary background, even if focally distributed by light microscopy and seemingly not recovered in the thick sections, correlated with the presence ultrastructurally of neuritic processes bearing dense core ("neurosecretory") granules and lucent vesicles. In three cases without any fibrillary background by light microscopy, granule-bearing processes were not found by electron microscopy, and different diagnoses were subsequently established for two of those cases. From the standpoint of diagnosis, the sampling error normally introduced in ultrastructural examinations has not been reported to be a significant problem, nor was it in the present cases. Therefore, in supporting a light microscopic diagnosis of neuroblastoma, neuritic processes containing dense granules with or without lucent vesicles should be documented. Neuroblastic tumors with evidence of maturity, ie, ganglion cell differentiation, had the best developed morphologic features by both forms of microscopy. Schwann cells were observed in four cases, including one neuroblastoma. The presence of these cells by electron microscopy, although absent by light microscopy, may reflect an early phase of tumor maturation.

Entities:  

Mesh:

Year:  1980        PMID: 6893122

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

1.  Esthesioneuroblastoma: a nasal catecholamine-producing tumor of neural crest origin. Demonstration of tyrosine hydroxylase-immunoreactive tumor cells.

Authors:  H Takahashi; K Wakabayashi; F Ikuta; K Tanimura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.

Authors:  Shizhen Zhu; Jeong-Soo Lee; Feng Guo; Jimann Shin; Antonio R Perez-Atayde; Jeffery L Kutok; Scott J Rodig; Donna S Neuberg; Daniel Helman; Hui Feng; Rodney A Stewart; Wenchao Wang; Rani E George; John P Kanki; A Thomas Look
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

Review 3.  Monoclonal antibodies as reagents for brain tumour diagnosis: a review.

Authors:  H B Coakham; J A Garson; B Brownell; J T Kemshead
Journal:  J R Soc Med       Date:  1984-09       Impact factor: 5.344

4.  Morphological investigations on cerebellar "neuroblastoma" group.

Authors:  S Yagishita; Y Itoh; Y Chiba; N Kuwana
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins.

Authors:  M Tsokos; S Scarpa; R A Ross; T J Triche
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

6.  Immunohistochemical localization of neurofilaments and neuron-specific enolase in 29 cases of neuroblastoma.

Authors:  M Osborn; T Dirk; H Käser; K Weber; M Altmannsberger
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

7.  Distribution of neurofilament protein and neuron-specific enolase in peripheral neuronal tumours.

Authors:  A Sasaki; A Ogawa; Y Nakazato; Y Ishida
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

8.  Expression of markers shared between human natural killer cells and neuroblastoma lines.

Authors:  R C McGarry; A Pinto; D R Hammersley-Straw; C L Trevenen
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Ultrastructural features of neuroblastic tumours in relation to morphological, and molecular findings; a retrospective review study.

Authors:  Elizabeth Latimer; Glenn Anderson; Neil James Sebire
Journal:  BMC Clin Pathol       Date:  2014-03-31

10.  No evidence for involvement of SDHD in neuroblastoma pathogenesis.

Authors:  Katleen De Preter; Jo Vandesompele; Jasmien Hoebeeck; Caroline Vandenbroecke; Jöel Smet; Annick Nuyts; Geneviève Laureys; Valérie Combaret; Nadine Van Roy; Frank Roels; Rudy Van Coster; Marleen Praet; Anne De Paepe; Frank Speleman
Journal:  BMC Cancer       Date:  2004-08-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.